| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
19,370,000 |
| Market
Cap: |
776.74(K) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.0401 - $1.8 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Aravive is a clinical-stage biopharmaceutical company developing treatments designed to halt the progression of diseases, including cancer and fibrosis. Co.'s primary product candidate, batiraxcept, is a decoy protein that targets the GAS6-AXL signaling pathway. By capturing serum GAS6, batiraxcept starves the AXL pathway of its signal, potentially halting the biological programming that promotes disease progression. AXL receptor signaling plays a role in multiple types of malignancies by promoting metastasis, cancer cell survival, resistance to treatments, and immune suppression.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Shepard Jay |
President and CEO |
• • – |
2019-10-07 |
4 |
S |
$6.82 |
$27,295 |
D/D |
(4,004) |
72,754 |
|
- |
|
| Shepard Jay |
President and CEO |
• • – |
2019-05-10 |
4 |
S |
$6.11 |
$7,283 |
D/D |
(1,192) |
76,758 |
|
- |
|
| Shepard Jay |
President and CEO |
• • – |
2019-02-01 |
4 |
S |
$4.14 |
$8,955 |
D/D |
(2,163) |
81,950 |
|
- |
|
| Haas Kevin |
VP, Finance and PAO |
• – – |
2019-02-01 |
4 |
S |
$4.14 |
$845 |
D/D |
(204) |
10,933 |
|
- |
|
| Shepard Jay |
President and CEO |
• • – |
2018-12-21 |
4 |
S |
$3.22 |
$11,232 |
D/D |
(3,484) |
84,113 |
|
- |
|
| Haas Kevin |
VP, Finance and PAO |
• – – |
2018-12-21 |
4 |
S |
$3.22 |
$2,288 |
D/D |
(711) |
11,137 |
|
- |
|
| Shepard Jay |
President and CEO |
• • – |
2018-12-17 |
4 |
S |
$3.96 |
$44,561 |
D/D |
(11,247) |
87,597 |
|
- |
|
| Haas Kevin |
VP, Finance and PAO |
• – – |
2018-12-17 |
4 |
S |
$3.96 |
$4,612 |
D/D |
(1,164) |
11,848 |
|
- |
|
| Akkaraju Srinivas |
Director |
– • – |
2018-10-12 |
4 |
A |
$0.00 |
$0 |
D/D |
27,456 |
31,815 |
|
- |
|
| Giaccia Amato |
Director |
– • • |
2018-10-12 |
4 |
A |
$0.00 |
$0 |
D/D |
941,880 |
941,880 |
|
- |
|
| Shah Vinay |
Chief Financial Officer |
• – – |
2018-10-12 |
4 |
A |
$0.00 |
$0 |
D/D |
178,606 |
178,606 |
|
- |
|
| Zhang Eric |
Director |
– • – |
2018-10-12 |
4 |
A |
$0.00 |
$0 |
I/I |
859,766 |
859,766 |
|
- |
|
| Tabibiazar Raymond |
Director |
– • • |
2018-10-12 |
4 |
A |
$0.00 |
$0 |
D/D |
1,000,751 |
1,000,751 |
|
- |
|
| Westberg Paul |
SVP and Chief Business Officer |
• – – |
2018-06-15 |
4 |
S |
$2.30 |
$1,408 |
D/D |
(612) |
225,124 |
|
- |
|
| Haas Kevin |
VP, Finance and PAO |
• – – |
2018-06-15 |
4 |
S |
$2.30 |
$329 |
D/D |
(143) |
78,075 |
|
- |
|
| Akkaraju Srinivas |
Director |
– • – |
2018-06-13 |
4 |
B |
$2.13 |
$112,928 |
I/I |
53,018 |
2,682,554 |
2.1 |
- |
|
| Akkaraju Srinivas |
Director |
– • – |
2018-06-08 |
4 |
B |
$2.00 |
$463,160 |
I/I |
231,580 |
2,629,536 |
2.1 |
- |
|
| Akkaraju Srinivas |
Director |
– • – |
2018-06-07 |
4 |
B |
$1.85 |
$301,964 |
I/I |
163,224 |
2,397,956 |
2.1 |
- |
|
| Akkaraju Srinivas |
Director |
– • – |
2018-06-06 |
4 |
B |
$1.74 |
$1,149,585 |
I/I |
660,681 |
2,234,732 |
2.1 |
- |
|
| Shepard Jay |
President and CEO |
• • – |
2018-05-22 |
4 |
S |
$1.50 |
$13,848 |
D/D |
(9,232) |
593,066 |
|
- |
|
| Stout Jay S |
SVP, Technical Operations |
• – – |
2018-04-24 |
4 |
S |
$1.55 |
$7,524 |
D/D |
(4,854) |
185,646 |
|
- |
|
| Woody Tracy M |
Chief Commercial Officer |
• – – |
2018-03-23 |
4 |
S |
$1.75 |
$7,604 |
D/D |
(4,345) |
215,755 |
|
- |
|
| Haas Kevin |
VP, Finance and PAO |
• – – |
2018-02-08 |
4 |
S |
$1.80 |
$2,878 |
D/D |
(1,599) |
78,218 |
|
- |
|
| Westberg Paul |
SVP and Chief Business Officer |
• – – |
2018-02-08 |
4 |
S |
$1.80 |
$9,639 |
D/D |
(5,355) |
225,736 |
|
- |
|
| Shepard Jay |
President and CEO |
• • – |
2018-02-08 |
4 |
S |
$1.80 |
$26,003 |
D/D |
(14,446) |
602,298 |
|
- |
|
258 Records found
|
|
Page 2 of 11 |
|
|
